Therapeutic Antibody against Herpes Simplex Viruses type 1 and 2
This humanized monoclonal antibody efficiently neutralizes HSV fully in-dependent of complement or immune effector cell recruitment and completely abrogates viral cell-to-cell spread, a key mechanism by which HSV escapes humoral immune surveillance.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A chip unique in the world
A team from UPV and iPRONICS has manufactured the first universal, programmable and multifunctional photonic chip on the market. A team from the Photonics Research Laboratory (PRL)-iTEAM of the Universitat…
Advance in light-based computing
…shows capabilities for future smart cameras. UCLA-developed experimental device demonstrates ability to reduce glare in images. Researchers developing the next generation of computing technology aim to bring some light to…
Evidence for reversible oxygen ion movement during electrical pulsing
…enabler of the emerging ferroelectricity in binary oxides. In a recent study published in Materials Futures, researchers have uncovered a pivotal mechanism driving the emergence of ferroelectricity in binary oxides….
